Ulrike Flach - CompuGroup Medical Member of the Supervisory Board
| CMPVF Stock | USD 29.89 0.00 0.00% |
Executive
Dr. Ulrike Flach was Member of the Supervisory Board of CompuGroup Medical Aktiengesellschaft since May 14 2014. Until 2013 she was the Parliamentary State Secretary for the Federal Ministry of Health. From 1998 to 2013 she was a parliament member of the FDP constituency in Mlheim an der Ruhr. During this time period she was also the Chairman of the Education Committee Chairman of Research and Technology Assessment as well as the Deputy leader of the FDP. From 1969 to 1974 she studied applied linguistics at Johannes GutenbergUniversitaet Mainz and Ealing Technical College in London. In 1974 she completed her studies with the qualification as a certified translator. Until 2005 Dr. Flach was employed at Siemens AG Power Engineering as a certified translator. since 2014.
| Tenure | 10 years |
| Professional Marks | Ph.D |
| Phone | 49 261 8000 0 |
| Web | https://www.cgm.com |
CompuGroup Medical Management Efficiency
The company has return on total asset (ROA) of 0.033 % which means that it generated a profit of $0.033 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1153 %, meaning that it generated $0.1153 on every $100 dollars invested by stockholders. CompuGroup Medical's management efficiency ratios could be used to measure how well CompuGroup Medical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Adam Cahan | ProSiebenSat1 Media AG | N/A | |
| Sabine Eckhardt | ProSiebenSat1 Media AG | N/A | |
| Pete Docter | Walt Disney | N/A | |
| John Phillips | GE Aerospace | N/A | |
| Clara Melia | ITV PLC ADR | N/A | |
| Hugh Johnston | Walt Disney | 62 | |
| Gideon Blumenthal | Merck Company | N/A | |
| Ashley Bacon | JPMorgan Chase Co | 51 | |
| Ravi Radhakrishnan | American Express | 49 | |
| Ketan Mehta | ProSiebenSat1 Media AG | N/A | |
| Edward Gilligan | American Express | 54 | |
| Ken Paukowits | American Express | N/A | |
| Philipp Freise | ProSiebenSat1 Media AG | N/A | |
| David Fabricant | American Express | 46 | |
| Kevin Service | Verizon Communications | N/A | |
| Robin Leopold | JPMorgan Chase Co | 56 | |
| David Burns | GE Aerospace | N/A | |
| Sonia Coleman | Walt Disney | 51 | |
| Dirk Voigtlaender | ProSiebenSat1 Media AG | N/A | |
| Kevin Cox | American Express | 53 | |
| John Donnelly | JPMorgan Chase Co | 59 | |
Management Performance
| Return On Equity | 0.12 | |||
| Return On Asset | 0.033 |
CompuGroup Medical Leadership Team
Elected by the shareholders, the CompuGroup Medical's board of directors comprises two types of representatives: CompuGroup Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CompuGroup. The board's role is to monitor CompuGroup Medical's management team and ensure that shareholders' interests are well served. CompuGroup Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CompuGroup Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Angela Teufer, Connectivity DACH | ||
| Rene Obermann, Member of the Supervisory Board | ||
| Lothar Wild, Member of the Supervisory Board | ||
| Uwe Eibich, Executive VP of Central Europe and Member of Management Board | ||
| Klaus Esser, Deputy Chairman of the Supervisory Board | ||
| Emanuele Mugnani, MD Board | ||
| Ulrike Flach, Member of the Supervisory Board | ||
| Christian Teig, CFO, Fin. Director and Member of Management Board | ||
| Helge Wei, VP Connectivity | ||
| Hannes Reichl, MD Board | ||
| Alexander Weimer, Head Communications | ||
| Daniel Gotthardt, Member of the Supervisory Board | ||
| Michael Franz, Co Communication | ||
| Oliver Bruzek, Chief Affairs | ||
| Frank Gotthardt, Chairman of Management Board and CEO | ||
| MBA LLM, MD CFO | ||
| Claudia Thom, Co Relations | ||
| Eckart Pech, MD Board | ||
| Frank Brecher, Chief Process Officer and Member of Management Board | ||
| Karl Gruener, Member of the Supervisory Board |
CompuGroup Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is CompuGroup Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.12 | |||
| Return On Asset | 0.033 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 2.89 B | |||
| Shares Outstanding | 52.23 M | |||
| Shares Owned By Insiders | 50.30 % | |||
| Shares Owned By Institutions | 29.69 % | |||
| Price To Earning | 20.14 X | |||
| Price To Book | 2.49 X |
Pair Trading with CompuGroup Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CompuGroup Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CompuGroup Medical will appreciate offsetting losses from the drop in the long position's value.Moving together with CompuGroup Pink Sheet
| 0.82 | AAPL | Apple Inc Report 2nd of May 2024 | PairCorr |
Moving against CompuGroup Pink Sheet
| 0.93 | XOM | Exxon Mobil Corp Earnings Call This Week | PairCorr |
| 0.92 | GE | GE Aerospace Buyout Trend | PairCorr |
| 0.82 | BAC | Bank of America Aggressive Push | PairCorr |
| 0.82 | CVX | Chevron Corp Earnings Call This Week | PairCorr |
| 0.8 | AMZN | Amazon Inc Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to CompuGroup Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CompuGroup Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CompuGroup Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CompuGroup Medical SE to buy it.
The correlation of CompuGroup Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CompuGroup Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CompuGroup Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CompuGroup Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CompuGroup Medical SE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Complementary Tools for CompuGroup Pink Sheet analysis
When running CompuGroup Medical's price analysis, check to measure CompuGroup Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuGroup Medical is operating at the current time. Most of CompuGroup Medical's value examination focuses on studying past and present price action to predict the probability of CompuGroup Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuGroup Medical's price. Additionally, you may evaluate how the addition of CompuGroup Medical to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |